by qfrsolutions | Jun 24, 2016 | News
Source: Business Wire Pfizer Inc. (NYSE:PFE) today announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net...
by qfrsolutions | Jun 23, 2016 | News
Source: By Zeba Siddiqui MUMBAI (Reuters) – India’s largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative U.S. dermatology business, its U.S. chief said....
by qfrsolutions | Jun 15, 2016 | News
Source: FierceMedicalDevice Healthcare growth investor Essex Woodlands has backed Suneva Medical with a new $25 million financing aimed at expanding its marketing of the only FDA-approved dermal filler that’s specifically indicated for smile lines or facial acne...
by qfrsolutions | Jun 14, 2016 | News
Source: Reuters Microsoft Corp will buy LinkedIn Corp for $26.2 billion in its biggest-ever deal, a bold stroke by Microsoft CEO Satya Nadella in his efforts to make the venerable software company a major force in next-generation computing. By connecting widely used...
by qfrsolutions | May 31, 2016 | News
Source: Reuters Ireland-based Jazz Pharmaceuticals Plc will buy U.S.-based Celator Pharmaceuticals Inc in a cash deal valued at about $1.5 billion, to gain access to an investigational product in development for treating acute myeloid leukemia. Jazz Pharmaceuticals...
by qfrsolutions | May 25, 2016 | News
Source: Reuters The Securities and Exchange Commission is concerned about the way Canadian drugmaker Valeant Pharmaceuticals International Inc (VRX.TO) has been disclosing its “non-GAAP” financial measures, regulatory filings showed on Tuesday. The SEC has...
